Zara GP - Search Results

1

Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin.

Cavalli R, Bargoni A, Podio V, Muntoni E, Zara GP, Gasco MR. Cavalli R, et al. Among authors: zara gp. J Pharm Sci. 2003 May;92(5):1085-94. doi: 10.1002/jps.10368. J Pharm Sci. 2003. PMID: 12712429

2

Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats.

Zara GP, Bargoni A, Cavalli R, Fundarò A, Vighetto D, Gasco MR. Zara GP, et al. J Pharm Sci. 2002 May;91(5):1324-33. doi: 10.1002/jps.10129. J Pharm Sci. 2002. PMID: 11977108

3

Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues.

Zara GP, Cavalli R, Bargoni A, Fundarò A, Vighetto D, Gasco MR. Zara GP, et al. J Drug Target. 2002 Jun;10(4):327-35. doi: 10.1080/10611860290031868. J Drug Target. 2002. PMID: 12164381

4

Solid lipid nanoparticles as anti-inflammatory drug delivery system in a human inflammatory bowel disease whole-blood model.

Serpe L, Canaparo R, Daperno M, Sostegni R, Martinasso G, Muntoni E, Ippolito L, Vivenza N, Pera A, Eandi M, Gasco MR, Zara GP. Serpe L, et al. Among authors: zara gp. Eur J Pharm Sci. 2010 Mar 18;39(5):428-36. doi: 10.1016/j.ejps.2010.01.013. Epub 2010 Feb 4. Eur J Pharm Sci. 2010. PMID: 20138213

5

Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats.

Bargoni A, Cavalli R, Caputo O, Fundarò A, Gasco MR, Zara GP. Bargoni A, et al. Among authors: zara gp. Pharm Res. 1998 May;15(5):745-50. doi: 10.1023/a:1011975120776. Pharm Res. 1998. PMID: 9619784

6

Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).

Zara GP, Cavalli R, Fundarò A, Bargoni A, Caputo O, Gasco MR. Zara GP, et al. Pharmacol Res. 1999 Sep;40(3):281-6. doi: 10.1006/phrs.1999.0509. Pharmacol Res. 1999. PMID: 10479474

7

Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats.

Fundarò A, Cavalli R, Bargoni A, Vighetto D, Zara GP, Gasco MR. Fundarò A, et al. Among authors: zara gp. Pharmacol Res. 2000 Oct;42(4):337-43. doi: 10.1006/phrs.2000.0695. Pharmacol Res. 2000. PMID: 10987994

8

Biodistribution of stealth and non-stealth solid lipid nanospheres after intravenous administration to rats.

Podio V, Zara GP, Carazzonet M, Cavalli R, Gasco MR. Podio V, et al. Among authors: zara gp. J Pharm Pharmacol. 2000 Sep;52(9):1057-63. doi: 10.1211/0022357001774976. J Pharm Pharmacol. 2000. PMID: 11045885

9

Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I--a pharmacokinetic study.

Cavalli R, Zara GP, Caputo O, Bargoni A, Fundarò A, Gasco MR. Cavalli R, et al. Among authors: zara gp. Pharmacol Res. 2000 Dec;42(6):541-5. doi: 10.1006/phrs.2000.0737. Pharmacol Res. 2000. PMID: 11058406

10

Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distribution.

Bargoni A, Cavalli R, Zara GP, Fundarò A, Caputo O, Gasco MR. Bargoni A, et al. Among authors: zara gp. Pharmacol Res. 2001 May;43(5):497-502. doi: 10.1006/phrs.2001.0813. Pharmacol Res. 2001. PMID: 11394943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters